Age, ATA risk group and response to therapy are prognostic factors in children with differentiated thyroid cancer.

Antje RedlichMarkus LusterKerstin LorenzLienhard LesselTilman R RohrerKurt W SchmidMichael C FrühwaldPeter VorwerkMichaela Kuhlen

Published in: The Journal of clinical endocrinology and metabolism (2021)

Age, ATA risk group, and response to therapy emerged as significant prognostic factors for EFS in pediatric patients with DTC, requiring risk-adapted individualized therapy and follow-up.

Keyphrases

prognostic factors
young adults
stem cells
replacement therapy